Global CNS Therapeutics Industry

Global CNS Therapeutics Industry

  • May 2018 •
  • 611 pages •
  • Report ID: 1139068
This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer’s, Anti-Parkinson’s, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants, and Others.

 The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.  Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 162 companies including many key and niche players such as:
-  AbbVie Inc.
- Alkermes Plc
-   Allergan, Plc
- Amneal Pharmaceuticals, LLC
-  AstraZeneca Plc
- BIAL Group
Country=APAC Industry=Therapy ParentIndustry=LifeSciences Date=201805 Publisher=GlobalIndustryAnalysts Price=6000